Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose
- PMID: 11567948
- PMCID: PMC1718944
- DOI: 10.1136/adc.85.4.339
Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose
Abstract
An Asian girl presented with failure to thrive, congenital hepatic fibrosis, protein losing enteropathy, and hypoglycaemia. Phosphomannose isomerase activity in skin fibroblasts was reduced. She is homozygous for a mutation, D131N, in the phosphomannose isomerase gene (PM1), consistent with the diagnosis of carbohydrate deficient glycoprotein syndrome type 1b. She responded to oral mannose treatment.
Similar articles
-
[Carbohydrate-deficient glycoprotein syndrome (CDGS) type Ib. A hereditary metabolic disease and its therapy].MMW Fortschr Med. 2000 Jan 20;142(3 Suppl):171-2. MMW Fortschr Med. 2000. PMID: 10783607 German.
-
Carbohydrate-deficient glycoprotein syndrome 1b: a new answer to an old diagnostic dilemma.J Paediatr Child Health. 2001 Oct;37(5):510-2. doi: 10.1046/j.1440-1754.2001.00671.x. J Paediatr Child Health. 2001. PMID: 11885720
-
Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose.J Pediatr. 1999 Sep;135(3):379-83. doi: 10.1016/s0022-3476(99)70139-3. J Pediatr. 1999. PMID: 10484808
-
Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency).Biochim Biophys Acta. 1999 Oct 8;1455(2-3):155-65. doi: 10.1016/s0925-4439(99)00073-3. Biochim Biophys Acta. 1999. PMID: 10571009 Review.
-
Molecular basis of carbohydrate-deficient glycoprotein syndromes type I with normal phosphomannomutase activity.Biochim Biophys Acta. 1999 Oct 8;1455(2-3):167-78. doi: 10.1016/s0925-4439(99)00072-1. Biochim Biophys Acta. 1999. PMID: 10571010 Review.
Cited by
-
Liver transplantation recovers hepatic N-glycosylation with persistent IgG glycosylation abnormalities: Three-year follow-up in a patient with phosphomannomutase-2-congenital disorder of glycosylation.Mol Genet Metab. 2023 Apr;138(4):107559. doi: 10.1016/j.ymgme.2023.107559. Epub 2023 Mar 17. Mol Genet Metab. 2023. PMID: 36965289
-
Identification and characterization of circulating immune complexes in IgA nephropathy.Sci Adv. 2022 Oct 28;8(43):eabm8783. doi: 10.1126/sciadv.abm8783. Epub 2022 Oct 28. Sci Adv. 2022. PMID: 36306365 Free PMC article.
-
Treatment Options in Congenital Disorders of Glycosylation.Front Genet. 2021 Sep 10;12:735348. doi: 10.3389/fgene.2021.735348. eCollection 2021. Front Genet. 2021. PMID: 34567084 Free PMC article. Review.
-
Fructose and Mannose in Inborn Errors of Metabolism and Cancer.Metabolites. 2021 Jul 25;11(8):479. doi: 10.3390/metabo11080479. Metabolites. 2021. PMID: 34436420 Free PMC article. Review.
-
Liver Involvement in Congenital Disorders of Glycosylation and Deglycosylation.Front Pediatr. 2021 Jul 5;9:696918. doi: 10.3389/fped.2021.696918. eCollection 2021. Front Pediatr. 2021. PMID: 34291020 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical